RICHARDSON PETER C (EVP, R&D Chief Medical Officer) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/14/2021ACC: 0001209191-21-040338
Officer· EVP, R&D Chief Medical Officer
Since Apr 2021
+105.24K
Net shares
Net buyer
$160.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
105.24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36.20K
Price / share
$4.42
Trade value
$160K
% of position
New position
6/10/2021
0.00→36.20K
Total
Net shares
+36.20K
Net value
$160K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2021 | A · Award | +36.20K | $4.42 | $160K | New position | 0.00 | 36.20K |
| Total | +36.20K | $160K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
69.04K shares
Shares
+69.04K
Strike price
4.42
Held after
69.04K
Exercisable
—
6/10/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock69.04K shares | 6/10/2021 | A · Award | +69.04K | 4.42 | — | 69.04K |